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Acute Myeloid Leukemia in a Dog Chronically Infected with  
Leishmania spp. and Other Infectious Agents
Leucemia mieloide aguda em cão infectado cronicamente por  
Leishmania spp. e outros agentes infecciosos
José Artur Brilhante Bezerra1, Ramon Tadeu Galvão Alves Rodrigues2, Isabelle de Oliveira Lima1,  
André Menezes do Vale1 & Kilder Dantas Filgueira1
ABSTRACT
Background: Rare studies have described the association of hematopoietic tumors and canine visceral leishmaniosis, 
however the association between the parasitary disease and neoplasia is still not well established in dogs. Thus, the aim of 
the present study was to report a case of acute myeloid leukemia (AML) in a dog infected by Leishmania spp. and other 
infectious agents.
Case: A 8-year-old, male Poodle, was brought to the Veterinary Hospital from Universidade Federal Rural do Semi-Árido. 
The dog had a history of recurrent tick-borne diseases, such as anaplasmosis, over the previous ten months. On physical 
examination, pale mucosa, enlargement of popliteal lymph nodes, onychogryphosis, purulent nasal discharge, and bilateral 
blepharitis with purulent discharge were observed. The dog was skinny and infested with ticks. The blood cell count revealed 
normocytic, normochromic anemia and leukocytosis (38.000/mm3) with neutrophilia (30.020/mm3). Serum biochemical 
tests demonstrated hyperproteinemia due to hyperglobulinemia, hypoalbuminemia, and an albumin:globulin ratio of 0.30. 
The immunochromathographic test for leishmaniasis was negative. The alterations observed in the bone marrow cytological 
analysis were suggestive of AML, and Anaplasma spp., Hepatozoon spp., and amastigote forms of Leishmania spp. were 
observed inside bone marrow cells. After diagnosis, a decision to euthanize the animal was made.
Discussion: Few studies have demonstrated the presence of hematopoietic neoplasia in dogs chronically and simultane-
ously infected with multiple pathogens. A case of multiple myeloma in a dog associated with infection by Ehrlichia canis, 
A. phagocytophilum, L. infantum, and Dirofilaria immitis is described. Another study reported B-cell lymphoma in a dog 
with E. canis and Histoplasma capsulatum infection. The pathogenesis of AML in the reported dog might be associated 
with continuous antigenic stimulation and chronic inflammation caused by the infectious agents. The pathological changes 
in bone marrow caused by Leishmania are well described, and different combinations of hypoplasia, hyperplasia, or dys-
plasia of all hematopoietic lineages can occur. The inflammation and chronic stimulation of hematopoiesis can lead to an 
increased risk of changes in the genetic material of the hematopoietic precursor cells. Thus, there is an increased chance 
of generation of mutated clones, resulting in hematopoietic malignancies. Immunosuppression is a common condition 
present in numerous types of neoplasia, especially in those with hematopoietic origins, which increases the vulnerability to 
opportunistic diseases. In humans, the presence of concomitant neoplasia and leishmaniasis is well documented, However, 
there are very few veterinary medicine studies on the association between neoplasia and canine visceral leishmaniosis. 
Cases of hematopoietic tumors, such as multiple myeloma, and multicentric, cutaneous, and cardiac lymphomas, have been 
described in dogs with leishmaniasis. To the best of our knowledge, this is possibly the first report implicating pathogens of 
the genera Leishmania, Anaplasma and Hepatozoon as contributors in the etiopathogenesis of AML in the studied animal. 
Based on all clinical and laboratory findings, we theorize that the prolonged antigenic stimulation and chronic inflamma-
tion caused by the infectious agents played a crucial role in the development of leukemia in the dog.
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INTRODUCTION
Canine visceral leishmaniosis (CVL) is an 
infectious contagious and parasitary chronic disease, 
caused by the protozoan Leishmania chagasi (syn. L. 
infantum), that leads to the manifestation of various 
unspecific clinical signs, in special viscerocutaneous 
signs [1]. Leishmania amastigote forms parasite cells 
from mononuclear phagocytic system, which are pre-
sent in lymphoid organs, such as lymph nodes, spleen, 
liver and bone marrow [1]. It is known that L. chagasi 
infection triggers a series of bone abnormalities, in-
cluding dysplastic changes and eritrophagocitosis [5].
Rare studies have described the association of 
hematopoietic tumors and CVL [3,4,6,10]. It has been 
suggested that the prolonged antigenic stimulation and 
chronic immunosuppression in dogs with leishmaniosis 
can play a crucial role on the etiopathogenesis of hema-
topoietic malignancies in these animals [5]. However, 
studies regarding the association of myeloid neoplasia 
and CVL are very rare. Thus, the aim of this report was 
to describe a case of acute myeloid leukemia (AML) 
associated with visceral leishmaniosis and other infec-
tious diseases in a dog.
CASE
A 8-year-old, male Poodle, was brought to 
the Veterinary Hospital (HOVET)of the Universidade 
Federal Rural do Semi-Árido (UFERSA). The patient 
had a history of recurrent thick-borne diseases, such 
as anaplasmosis, over the previous ten months and had 
already been treated with doxycycline and other antibio-
tics, but did not have a favorable therapeutic response.
Pale mucosa, enlargement of popliteal lymph 
nodes, onychogryphosis, purulent nasal discharge, 
and bilateral blepharitis with purulent discharge were 
observed during the physical examination. The dog 
was skinny and infested with ticks.
Complete blood cell counts, hepatic and renal 
serum profiles, an immunochromathographic test for 
the detection of antibodies against L. chagasi (Alere 
Leishmaniose Ac Test Kit)1, and fine-needle aspiration of 
bone marrow for cytologic evaluation were all requested.
Normocytic, normochromic anemia was de-
tected (red blood cell count: 3.2 million/mm3; hemo-
globin: 7.1 g/dL; hematocrit: 23%; mean corpuscular 
volume [MCV]: 70 u3; mean corpuscular hemoglobin 
concentration [MCHC]: 31%). Leukocytosis with 
neutrophilia (white blood cell count: 38.000/mm3; 
neutrophil count: 30.020/mm3) was also observed.
The biochemical abnormalities detected in-
cluded hyperproteinemia (8.19 g/dL) resulting from 
hyperglobulinemia (6.29 g/dL), hypoalbuminemia (1.9 
g/dL), and an albumin:globulin ratio of 0.30. The result 
of the immunochromatographic test for leishmaniasis 
was negative.
The alterations observed in the cytological 
analysis of the bone marrow were suggestive of AML 
(Figure 1). Furthermore, Anaplasma spp., Hepatozoon 
spp., and amastigote forms of Leishmania spp. were 
observed inside the bone marrow cells (Figure 2). After 
the diagnosis of CVL associated with AML, a decision 
was made to euthanize the animal, and necropsy was 
not authorized.
DISCUSSION
Few studies have demonstrated the presence of 
hematopoietic neoplasia in dogs chronically and simulta-
neously infected with multiple pathogens. Geigy et al. [6] 
described a case of multiple myeloma in a dog associated 
with infection by Ehrlichia canis, A. phagocytophilum, L. 
infantum, and Dirofilaria immitis. Another study reported 
B-cell lymphoma in a dog with E. canis and Histoplasma 
capsulatum infection [2]. In both manuscripts, the au-
thors suggested that the pathogenesis of the tumors might 
be associated with continuous antigenic stimulation and 
chronic inflammation caused by the infectious agents. 
These hypotheses could also be applied to our case, in 
which the animal was chronically infected with various 
pathogens when AML developed.
In humans, the presence of concomitant ne-
oplasia and leishmaniasis is well documented. Kop-
terides et al. [8] have established the following four 
associations between leishmaniasis and cancer: 1) 
leishmaniasis can mimic a malignant disorder, such 
as lymphoma; 2) in patients receiving chemotherapy 
for various malignant disorders, leishmaniasis can 
present as an infection that is difficult to diagnose 
and treat; 3) in immunocompromised patients, it is 
possible to obtain a simultaneous diagnosis of leish-
maniasis and a neoplastic disorder in the same tissue 
samples; 4) Leishmania spp. is directly involved in the 
pathogenesis and development of malignant lesions, 
an association which we considered as a hypothesis 
in our case [8].
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Due to the high prevalence of CVL in endemic 
areas, the coexistence of these conditions might be a 
coincidence. However, there are very few veterinary 
medicine studies on the association between neoplasia 
and CVL. Cases of hematopoietic tumors, such as 
multiple myeloma, and multicentric, cutaneous, and 
cardiac lymphomas, have been described in dogs with 
leishmaniasis [3,4,6,10]. To the best of our knowledge, 
this is possibly the first report implicating pathogens 
of the genera Leishmania, Anaplasma and Hepatozoon 
as contributors in the etiopathogenesis of AML in the 
studied animal. This association was made based on 
the fact that some blood parasites, such as Leishmania 
spp., target organs rich in cells of the mononuclear 
phagocytic system, such as lymph nodes and bone mar-
row, causing a series of injuries. The chronic antigenic 
stimulation may contribute to neoplastic transformation 
resulting in AML. The pathological changes in bone 
marrow caused by Leishmania are well described, and 
different combinations of hypoplasia, hyperplasia, or 
dysplasia of all hematopoietic lineages can occur [5].
The inflammation and chronic stimulation of 
hematopoiesis can lead to an increased risk of changes 
in the genetic material of the hematopoietic precursor 
cells. Thus, there is an increased chance of generation 
of mutated clones, resulting in hematopoietic malig-
nancies [7]. This citation reinforced our hypothesis 
that the hemoparasites exerted an important role in the 
development of AML in the dog in our study.
In the current study, a diagnosis of CVL was 
obtained only by direct parasitological examination, 
using fine-needle aspiration of the bone marrow, des-
pite negative serology for leishmaniasis. Although the 
serological methods present a satisfactory sensitivity 
and specificity, failure can occur in some situations - for 
example, when the animal is in the prepatent period, since 
the average time for seroconversion is five months. There 
are individuals that will never seroconvert; some animals 
are seropositive and convert to seronegative, but remain 
infected [1,9]. With regard to the dog reported in our study, 
we hypothesize that due to the chronicity of the infection, 
the dog became anergic, ceasing production of antibodies 
against Leishmania; however, it was still infected by the 
protozoan. Hence, the serological test result was negative.
Immunosuppression is a common condition 
present in numerous types of neoplasia, especially in 
those with hematopoietic origins, which increases the 
vulnerability to opportunistic diseases [11]. For this 
reason, it is of fundamental importance that the presen-
ce of CVL and other hemoparasites be investigated in 
dogs affected by oncologic diseases, since coinfections 
represent a complicating factor in the treatment of the 
animal. Most oncological therapeutics also predispose 
the patient to immunosuppression, further deteriora-
ting the general health of the animal when infectious 
diseases are acquired. Thus, the prevention of such 
disorders is mandatory during antineoplastic treatment, 
especially in areas in which CVL is endemic.
Figure 2. Hemoparasites observed on bone marrow cytological 
examination. A- Leishmania spp. (arrow); B- Hepatozoon spp. (arrow); 
C- Anaplasma spp. (arrow) [Diff-Quick staining, 100x magnification].
Figure 1. Bone marrow cytological photomicrograph showing blastic 
cells with malignancy criteria, such as mitosis figures and maturative 
asynchronism (Diff-Quick staining, 100x magnification).
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Further studies are still necessary to investigate 
and elucidate the influence of microorganisms of the 
genera Leishmania, Anaplasma, and Hepatozoon on 
the genesis of some neoplasms. We strongly believe 
that these pathogens played an important role in the 
development of AML in the reported dog. 
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